Document ID: chunk:federal_register_of_legislation:F2024L00752:reg:9:p1
Version: federal_register_of_legislation:F2024L00752
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 4156–7340

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, duodenal ulcer and duodenal erosion or death from duodenal ulcer and duodenal erosion is connected with the circumstances of a person's relevant service:
(1)          having Helicobacter pylori infection of the duodenum at the time of clinical onset or clinical worsening;
(2)           having an infection of the duodenal mucosa by one of the following organisms:

            (a)          cytomegalovirus;
            (b)          herpes simplex virus;
            (c)          fungi (such as Candida species or Histoplasma capsulatum);
            (d)          Helicobacter heilmannii;
            (e)          Mycobacterium tuberculosis;
            (f)           Strongyloides stercoralis (causing strongyloidiasis);

         at the time of clinical onset or clinical worsening;
(3)          having a critical illness or injury within the 14 days before clinical onset or clinical worsening;
Note: critical illness or injury is defined in the Schedule 1 - Dictionary.
(4)          undergoing a course of radiotherapy for cancer, where the stomach or duodenum was in the field of radiation, within the 6 months before  clinical onset or clinical worsening;
(5)          undergoing 90Yttrium microsphere therapy for primary and metastatic liver tumours, within the 6 months before clinical onset or clinical worsening;
(6)          having contact with a nasogastric tube or other foreign objects or extraneous material at the site of the ulcer or erosion at the time of clinical onset or clinical worsening;
(7)          having Roux-en-Y gastric bypass within the 5 years before clinical onset or clinical worsening of duodenal ulcer or duodenal erosion, where the ulcer or erosion occurred at the site of the surgical anastomosis;
(8)          having a gastrin-secreting tumour at the time of clinical onset or clinical worsening;
(9)          smoking at least 10 cigarettes per day, or the equivalent thereof in other tobacco products, for at least the 12 months before clinical onset or clinical worsening;
(10)      being treated with a non-topical non-steroidal anti-inflammatory drug, or aspirin, at least every other day during a continuous period of at least 14 days, within the 3 months before clinical onset or clinical worsening;
(11)      having a solid organ or bone marrow transplant before clinical onset or clinical worsening;
(12)      being treated with an antineoplastic agent within the 3 months before clinical onset or clinical worsening;
Note: antineoplastic agent is defined in the Schedule 1 - Dictionary.
(13)      being treated with one of the following drugs or class of drugs at the time of clinical onset or clinical worsening:
(a)          bisphosphonate, including alendronate;
(b)          chemotherapeutic agents delivered by hepatic arterial infusion; or
(c)          potassium chloride tablet (enteric coated or wax formulation);
(14)      being treated with one of the following drugs or class of drugs for at least 2 weeks, within the 3 months before clinical onset;
(a)          clopidogrel;